J Korean Neurol Assoc.
2017 Nov;35(4):235-236. 10.17340/jkna.2017.4.11.
Hypersexuality Induced by Rasagiline Monotherapy in a Patinet with Parkinson's Disease
- Affiliations
-
- 1Department of Neurology, Korea University Guro Hospital, Seoul, Korea. Parkinson@korea.ac.kr
- KMID: 2405986
- DOI: http://doi.org/10.17340/jkna.2017.4.11
Abstract
- Impulse control disorders including hypersexuality occur occasionally in Parkinson's disease, especially when treated with dopamine agonist. A 62-year-old male with Parkinson's disease was initially treated with rasagiline monotherapy and presented hypersexuality. After 8 weeks of discontinuation of the drug, his hypersexual behavior was significantly improved. To our knowledge, this is the first reported Asian case of a hypersexuality caused by rasagiline. Our observation emphasizes that patients and caregivers need to be educated on the possibility of hypersexuality resulting from rasagiline.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- MAO-inhibitors in Parkinson's Disease
- Modafinil Dependence and Hypersexuality: A Case Report and Review of the Evidence
- A Clinical Study for the Efficacy and Safety of Selegiline HCI(MAO-B(R)) in Parkinson's Disease
- Pharmacological Treatment in Parkinson's Disease
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
